Four concepts that define the framework
Before laboratory analysis can occur, a specimen must first be successfully obtained.
This stage includes:
• specimen collection attempts
• patient and workflow conditions
• factors affecting collection success
Access Before Analysis™ examines this stage directly.
Not all encounters result in successful specimen collection.
Access variability may occur due to:
• patient age or developmental needs
• clinical workflow conditions
• escalation during collection attempts
• environmental or staffing factors
Understanding this variability can help clarify workflow challenges.
When specimen access is difficult, escalation may occur.
Examples include:
• multiple collection attempts
• additional staff support
• deferred testing
• abandoned collection
Documenting these patterns provides insight into how encounters evolve in real clinical settings.
Some encounters result in no specimen at all.
These events often do not appear in traditional laboratory metrics, which only capture completed specimens.
This framework helps bring visibility to these missing encounters.
This work generates observational insight—not analytic comparison.
Outputs may include:
Access Before Analysis™ is intentionally scoped.
This work:
It is strictly observational, designed to characterize pre-analytic access variability.
When specimen access fails, downstream diagnostic processes cannot begin.
These encounters may represent:
• delayed diagnostics
• additional patient visits
• workflow burden
• missed measurement opportunities
By documenting the upstream pre-analytic layer, organizations gain a clearer understanding of where improvement efforts may begin.
• your care setting
• pediatric specimen access challenges
• potential pilot scope
• lab leaders
• quality teams
• innovation leaders
• pediatric care stakeholders
Device and Diagnostic companies
• observational access mapping
• workflow review
• escalation point identification
• summary outputs
Initial conversation: 15–20 minutes
No workflow disruption. No performance evaluation. Observational only.
Access Before Analysis™ is a trademarked framework currently in structured pilot-stage development. Franchesca Kelly franchesca@accessbeforeanalysis.com
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.